Clinical trial

Clinical Study Comparing Diosmin vs Rebamipide as Adjuvant Therapies vs Conventional Therapy in Patients With Rheumatoid Arthritis

NCT07745426

Study summary

ClinicalTrials.gov

Clinical Study Comparing Diosmin vs Rebamipide as Adjuvant Therapies vs Conventional Therapy in Patients With Rheumatoid Arthritis

Design: INTERVENTIONAL · Status: RECRUITING · Phase: PHASE2

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Mapped RxNorm record Diosmin Normalized identity: diosmin View linked drug · Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Rebamipide 100mg Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Convential medical treatment Find medicine records · Find other trials using this name

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2026-08-01

PhasePHASE2

Conditions

Rheumatoid Arthritis (RA)unresolved

Interventions

DiosminDRUG · verified · RxNorm: diosmin

Rebamipide 100mgDRUG

Convential medical treatmentDRUG

Sponsors & collaborators

Tanta Universitylead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07745426 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.